Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PROSTATE CANCER, . Treffer: 166

2020

Brausi, M; Hoskin, P; Andritsch, E; Banks, I; Beishon, M; Boyle, H; Colecchia, M; Delgado-Bolton, R; Höckel, M; Leonard, K; Lövey, J; Maroto, P; Mastris, K; Medeiros, R; Naredi, P; Oyen, R; de Reijke, T; Selby, P; Saarto, T; Valdagni, R; Costa, A; Poortmans, P ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.
Crit Rev Oncol Hematol. 2020; 148: 102861-102861.
Web of Science PubMed FullText FullText_MUG

 

Hofmann, L; Kroneis, T; El-Heliebi, A Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells.
Methods Mol Biol. 2020; 2148:361-378
PubMed FullText FullText_MUG

 

Kaiser, M; Thurner, EM; Mangge, H; Herrmann, M; Semeraro, MD; Renner, W; Langsenlehner, T Haptoglobin polymorphism and prostate cancer mortality.
Sci Rep. 2020; 10(1): 13117-13117.
PubMed FullText FullText_MUG

 

Lu, C; Terbuch, A; Dolling, D; Yu, J; Wang, H; Chen, Y; Fountain, J; Bertan, C; Sharp, A; Carreira, S; Isaacs, WB; Antonarakis, ES; De Bono, JS; Luo, J Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype.
Ann Oncol. 2020;
PubMed FullText FullText_MUG

 

2019

Calabria, F; Pichler, R; Leporace, M; Wolfsgruber, J; Coscarelli, P; Dunzinger, A; Schillaci, O; Cascini, GL; Bagnato, A 68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.
Curr Radiopharm. 2019; 12(3):238-246
PubMed FullText FullText_MUG

 

Chen, S; Tauber, G; Langsenlehner, T; Schmölzer, LM; Pötscher, M; Riethdorf, S; Kuske, A; Leitinger, G; Kashofer, K; Czyż, ZT; Polzer, B; Pantel, K; Sedlmayr, P; Kroneis, T; El-Heliebi, A In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
Cancers (Basel). 2019; 11(7): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Grubmüller, B; Senn, D; Kramer, G; Baltzer, P; D'Andrea, D; Grubmüller, KH; Mitterhauser, M; Eidherr, H; Haug, AR; Wadsak, W; Pfaff, S; Shariat, SF; Hacker, M; Hartenbach, M Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging. 2019; 46(5):1063-1072 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kardoust Parizi, M; Iwata, T; Kimura, S; Janisch, F; Abufaraj, M; Karakiewicz, PI; Enikeev, D; Rapoport, LM; Hutterer, G; Shariat, SF Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2019; 20(6): 1374 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mahmoudian, J; Ghods, R; Nazari, M; Jeddi-Tehrani, M; Ghahremani, MH; Ghaffari-Tabrizi-Wizsy, N; Ostad, SN; Zarnani, AH PLAC1: biology and potential application in cancer immunotherapy.
Cancer Immunol Immunother. 2019; 68(7): 1039-1058.
Web of Science PubMed FullText FullText_MUG

 

Pernthaler, B; Kulnik, R; Gstettner, C; Salamon, S; Aigner, RM; Kvaternik, H A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT.
Clin Nucl Med. 2019; 44(10): e566-e573-e566-e573.
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Ulz, P; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, W; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer. 2018; 143(5): 1236-1248. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Chen, S; El-Heliebi, A; Schmid, J; Kashofer, K; Czyż, ZT; Polzer, BM; Pantel, K; Kroneis, T; Sedlmayr, P Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.
J Vis Exp. 2018; (135): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

de Wit, S; Manicone, M; Rossi, E; Lampignano, R; Yang, L; Zill, B; Rengel-Puertas, A; Ouhlen, M; Crespo, M; Berghuis, AMS; Andree, KC; Vidotto, R; Trapp, EK; Tzschaschel, M; Colomba, E; Fowler, G; Flohr, P; Rescigno, P; Fontes, MS; Zamarchi, R; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Farace, F; De Bono, J; IJzerman, MJ; Terstappen, LWMM EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget. 2018; 9(86):35705-35716 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Speicher, MR Digital Circulating Tumor Cell Analyses for Prostate Cancer Precision Oncology.
Cancer Discov. 2018; 8(3): 269-271. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Markou, A; Lazaridou, M; Paraskevopoulos, P; Chen, S; Świerczewska, M; Budna, J; Kuske, A; Gorges, TM; Joosse, SA; Kroneis, T; Zabel, M; Sedlmayr, P; Alix-Panabières, C; Pantel, K; Lianidou, ES Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Clin Chem. 2018; 64(2):297-306 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Kaufmann, S; Russo, GI; Harland, N; Rausch, S; Amend, B; Scharpf, M; Loewe, L; Todenhoefer, T; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
BJU Int. 2018; 121(5):791-798 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583
Web of Science PubMed FullText FullText_MUG

 

Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; Lopez-Gitlitz, A; Trudel, GC; Espina, BM; Shu, Y; Park, YC; Rackoff, WR; Yu, MK; Small, EJ; SPARTAN Investigators Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med. 2018; 378(15): 1408-1418. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Strele-Trieb, P; Dunzinger, A; Sonnberger, M; Wolfsgruber, J; Pichler, R Uptake of 68Ga-Prostate-Specific Membrane Antigen PET in Adrenal Gland: A Potential Pitfall.
Clin Nucl Med. 2018; 43(1):50-51
Web of Science PubMed FullText FullText_MUG

 

2017

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jajić, I; Benčić, A; Siroglavić, M; Zarfel, G; Ružić, B; Pezelj, I; Bedenić, B Klebsiella Pneumoniaeoxa-48 in a Urology Patient: Case Report
Acta Clin Croat. 2017; 56(1):166-171 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kaufmann, S; Mischinger, J; Amend, B; Rausch, S; Adam, M; Scharpf, M; Fend, F; Kramer, U; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
World J Urol. 2017; 35(7):1023-1029
Web of Science PubMed FullText FullText_MUG

 

Mohamad Al-Ali, B; Kramer, G; Madersbacher, S; Berger, I Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization : Analysis of a medical claims database.
Wien Klin Wochenschr. 2017; 129(11-12):380-384 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Renner, W; Langsenlehner, U; Krenn-Pilko, S; Eder, P; Langsenlehner, T BCL2 genotypes and prostate cancer survival.
Strahlenther Onkol. 2017; 193(6):466-471 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wallner, M; Khafaga, M; Kolesnik, E; Vafiadis, A; Schwantzer, G; Eaton, DM; Curcic, P; Köstenberger, M; Knez, I; Rainer, PP; Pichler, M; Pieske, B; Lewinski, DV Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
Oncotarget. 2017; 8(30):49264-49274 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Bollen, L; Wibmer, C; Van der Linden, YM; Pondaag, W; Fiocco, M; Peul, WC; Marijnen, CA; Nelissen, RG; Leithner, A; Dijkstra, SP Predictive Value of Six Prognostic Scoring Systems for Spinal Bone Metastases: An Analysis Based on 1379 Patients.
Spine (Phila Pa 1976). 2016; 41(3):E155-E162
Web of Science PubMed FullText FullText_MUG

 

Kaushik, AK; Shojaie, A; Panzitt, K; Sonavane, R; Venghatakrishnan, H; Manikkam, M; Zaslavsky, A; Putluri, V; Vasu, VT; Zhang, Y; Khan, AS; Lloyd, S; Szafran, AT; Dasgupta, S; Bader, DA; Stossi, F; Li, H; Samanta, S; Cao, X; Tsouko, E; Huang, S; Frigo, DE; Chan, L; Edwards, DP; Kaipparettu, BA; Mitsiades, N; Weigel, NL; Mancini, M; McGuire, SE; Mehra, R; Ittmann, MM; Chinnaiyan, AM; Putluri, N; Palapattu, GS; Michailidis, G; Sreekumar, A Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.
Nat Commun. 2016; 7(7):11612-11612 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Langsteger, W; Rezaee, A; Loidl, W; Geinitz, HS; Fitz, F; Steinmair, M; Broinger, G; Pallwien-Prettner, L; Beheshti, M; Imamovic, L; Beheshti, M; Rendl, G; Hackl, D; Tsybrovsky, O; Steinmair, M; Emmanuel, K; Moinfar, F; Pirich, C; Langsteger, W; Bytyqi, A; Karanikas, G; Mayerhöfer, M; Koperek, O; Niederle, B; Hartenbach, M; Beyer, T; Herrmann, K; Czernin, J; Rausch, I; Rust, P; DiFranco, MD; Lassen, M; Stadlbauer, A; Mayerhöfer, ME; Hartenbach, M; Hacker, M; Beyer, T; Binzel, K; Magnussen, R; Wei, W; Knopp, MU; Flanigan, DC; Kaeding, C; Knopp, MV; Leisser, A; Nejabat, M; Hartenbach, M; Kramer, G; Krainer, M; Hacker, M; Haug, A; Lehnert, W; Schmidt, K; Kimiaei, S; Bronzel, M; Kluge, A; Wright, CL; Binzel, K; Zhang, J; Wuthrick, E; Maniawski, P; Knopp, MV; Blaickner, M; Rados, E; Huber, A; Dulovits, M; Kulkarni, H; Wiessalla, S; Schuchardt, C; Baum, RP; Knäusl, B; Georg, D; Bauer, M; Wulkersdorfer, B; Wadsak, W; Philippe, C; Haslacher, H; Zeitlinger, M; Langer, O; Bauer, M; Feldmann, M; Karch, R; Wadsak, W; Zeitlinger, M; Koepp, MJ; Asselin, MC; Pataraia, E; Langer, O; Zeilinger, M; Philippe, C; Dumanic, M; Pichler, F; Pilz, J; Hacker, M; Wadsak, W; Mitterhauser, M; Nics, L; Steiner, B; Hacker, M; Mitterhauser, M; Wadsak, W; Traxl, A; Wanek, T; Kryeziu, K; Mairinger, S; Stanek, J; Berger, W; Kuntner, C; Langer, O; Mairinger, S; Wanek, T; Traxl, A; Krohn, M; Stanek, J; Filip, T; Sauberer, M; Kuntner, C; Pahnke, J; Langer, O; Svatunek, D; Denk, C; Wilkovitsch, M; Wanek, T; Filip, T; Kuntner-Hannes, C; Fröhlich, J; Mikula, H; Denk, C; Svatunek, D; Wanek, T; Mairinger, S; Stanek, J; Filip, T; Fröhlich, J; Mikula, H; Kuntner-Hannes, C; Balber, T; Singer, J; Fazekas, J; Rami-Mark, C; Berroterán-Infante, N; Jensen-Jarolim, E; Wadsak, W; Hacker, M; Viernstein, H; Mitterhauser, M; Denk, C; Svatunek, D; Sohr, B; Mikula, H; Fröhlich, J; Wanek, T; Kuntner-Hannes, C; Filip, T; Pfaff, S; Philippe, C; Mitterhauser, M; Hartenbach, M; Hacker, M; Wadsak, W; Wanek, T; Halilbasic, E; Visentin, M; Mairinger, S; Stieger, B; Kuntner, C; Trauner, M; Langer, O; Lam, P; Aistleitner, M; Eichinger, R; Artner, C; Eidherr, H; Vraka, C; Haug, A; Mitterhauser, M; Nics, L; Hartenbach, M; Hacker, M; Wadsak, W; Kvaternik, H; Müller, R; Hausberger, D; Zink, C; Aigner, RM; Cossío, U; Asensio, M; Montes, A; Akhtar, S; Te Welscher, Y; van Nostrum, R; Gómez-Vallejo, V; Llop, J; VandeVyver, F; Barclay, T; Lippens, N; Troch, M; Hehenwarter, L; Egger, B; Holzmannhofer, J; Rodrigues-Radischat, M; Pirich, C; Pötsch, N; Rausch, I; Wilhelm, D; Weber, M; Furtner, J; Karanikas, G; Wöhrer, A; Mitterhauser, M; Hacker, M; Traub-Weidinger, T; Cassou-Mounat, T; Balogova, S; Nataf, V; Calzada, M; Huchet, V; Kerrou, K; Devaux, JY; Mohty, M; Garderet, L; Talbot, JN; Stanzel, S; Pregartner, G; Schwarz, T; Bjelic-Radisic, V; Liegl-Atzwanger, B; Aigner, R; Stanzel, S; Quehenberger, F; Aigner, RM; Marković, AK; Janković, M; Jerković, VM; Paskaš, M; Pupić, G; Džodić, R; Popović, D; Fornito, MC; Familiari, D; Koranda, P; Polzerová, H; Metelková, I; Henzlová, L; Formánek, R; Buriánková, E; Kamínek, M; Thomson, WH; Lewis, C; Thomson, WH; O'Brien, J; James, G; Notghi, A; Huber, H; Stelzmüller, I; Wunn, R; Mandl, M; Fellner, F; Lamprecht, B; Gabriel, M; Fornito, MC; Leonardi, G; Thomson, WH; O'Brien, J; James, G; Hudzietzová, J; Sabol, J; Fülöp, M 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
EJNMMI Res. 2016; 6(Suppl 1):32-32. [Keynote lecture] [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Meshcheryakova, A; Svoboda, M; Tahir, A; Köfeler, HC; Triebl, A; Mungenast, F; Heinze, G; Gerner, C; Zimmermann, P; Jaritz, M; Mechtcheriakova, D Exploring the role of sphingolipid machinery during the epithelial to mesenchymal transition program using an integrative approach.
Oncotarget. 2016; 7(16):22295-22323 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Müller, AC; Mischinger, J; Klotz, T; Gagel, B; Habl, G; Hatiboglu, G; Pinkawa, M Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients.
Radiol Oncol. 2016; 50(3):329-336 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rugani, P; Walter, C; Kirnbauer, B; Acham, S; Begus-Nahrman, Y; Jakse, N Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.
Dent J (Basel). 2016; 4(4): [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Schrem, H; Schneider, V; Kurok, M; Goldis, A; Dreier, M; Kaltenborn, A; Gwinner, W; Barthold, M; Liebeneiner, J; Winny, M; Klempnauer, J; Kleine, M Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
PLoS One. 2016; 11(7): e0158732-e0158732. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Augustin, H; Mayerhofer, K; Seles, M; Pummer, K Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dahlhaus, A; Semlitsch, T; Jeitler, K; Horvath, K; Siebenhofer, A Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
Fam Pract. 2015; 32(5):483-491 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fröhlich, E; Wahl, R Chemotherapy and chemoprevention by thiazolidinediones.
Biomed Res Int. 2015; 2015(3):845340-845340 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Langsenlehner, T; Pichler, M; Thurner, EM; Krenn-Pilko, S; Stojakovic, T; Gerger, A; Langsenlehner, U Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
Urol Oncol. 2015; 33(5): 201.e9-201201.
PubMed FullText FullText_MUG

 

Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667
Web of Science PubMed FullText FullText_MUG

 

Lucca, I; Shariat, SF; Briganti, A; Lotan, Y; Roehrborn, CG; Montorsi, F; Remzi, M; Seitz, C; Fajkovic, H; Klingler, C; Karakiewicz, PI; Sun, M; Rouprêt, M; Loidl, W; Pummer, K; Klatte, T Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Urol Oncol. 2015; 33(2):71.e21-71.e26
Web of Science PubMed FullText FullText_MUG

 

Mischinger, J; Comperat, E; Schwentner, C; Stenzl, A; Gakis, G Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?
Curr Urol Rep. 2015; 16(9):59-59
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Faber, F; Wallwiener, D; Schilling, D; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Fehm, T; Stenzl, A; Schwentner, C Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.
Prostate. 2015; 75(6):637-645
Web of Science PubMed FullText FullText_MUG

 

2014

Kaushik, AK; Vareed, SK; Basu, S; Putluri, V; Putluri, N; Panzitt, K; Brennan, CA; Chinnaiyan, AM; Vergara, IA; Erho, N; Weigel, NL; Mitsiades, N; Shojaie, A; Palapattu, G; Michailidis, G; Sreekumar, A Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.
J Proteome Res. 2014; 13(2):1088-1100 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kluth, LA; Abdollah, F; Xylinas, E; Rieken, M; Fajkovic, H; Seitz, C; Sun, M; Karakiewicz, PI; Schramek, P; Herman, MP; Becker, A; Hansen, J; Ehdaie, B; Loidl, W; Pummer, K; Lee, RK; Lotan, Y; Scherr, DS; Seiler, D; Ahyai, SA; Chun, FK; Graefen, M; Tewari, A; Nonis, A; Bachmann, A; Montorsi, F; Gönen, M; Briganti, A; Shariat, SF Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
Br J Cancer. 2014; 111(2):213-219 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum